ICICI Direct is bullish on SBI Life Insurance has recommended buy rating on the stock with a target price of Rs 800 in its research report dated April 26, 2019
ICICI Direct's research report on SBI Life Insurance
SBI Life reported healthy growth in premium at 22.5% YoY to Rs 11380 crore, led by robust traction in renewals (27.7% YoY) and healthy growth in new business premium (NBP). Traction in both - individual (16% YoY) and group NBP (12% YoY) remained healthy. Focus on protection business has led to a rise in its proportion to ~12% in FY19 vs. ~6% in FY18. AUM growth remained healthy at 21% YoY to Rs 141020 crore.
Strong distribution network, cost control & focus on high margin protection business and rising persistency are expected to result in healthy operating RoEV at ~18% in FY20-21E. Rolling our valuation to FY21E, we revise our target price to Rs 800, valuing the stock at 2.6x FY21 EV.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Get Lok Sabha 2019 Live Election Results, constituency-wise tally, news, views and analysis
Follow our Lok Sabha Election Result Live Blog here.